TGen, Scottsdale Healthcare lead worldwide study of new drug for patients with pancreatic cancer
- Details
- Category: Research
A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to results of a Phase III clinical trial led by physicians from Scottsdale Healthcare's Virginia G. Cancer Center Clinical Trials, a partnership with the Translational Genomics Research Institute (TGen).
Study shows large-scale genomic testing feasible, impacts therapy
- Details
- Category: Research
Targeted cancer therapy has been transforming the care of patients with non-small-cell lung cancer (NSCLC). It is now standard practice for tumor specimens from NSCLC patients to be examined for EGFR mutations and ALK rearrangements to identify patients for therapy with EGFR and ALK inhibitors, respectively.
Compound in grapes, red wine could be key to fighting prostate cancer
- Details
- Category: Research
Resveratrol, a compound found commonly in grape skins and red wine, has been shown to have several beneficial effects on human health, including cardiovascular health and stroke prevention. Now, a University of Missouri researcher has discovered that the compound can make prostate tumor cells more susceptible to radiation treatment, increasing the chances of a full recovery from all types of prostate cancer, including aggressive tumors.
A completely new way of delivering anti-cancer drugs
- Details
- Category: Research
A completely new way of delivering anti-cancer drugs to tumours, using 'minicells' derived from bacteria, has been tested for the first time in humans and found to be safe, well-tolerated and even induced stable disease in patients with advanced, incurable cancers with no treatment options remaining.
New drug significantly lowers bad cholesterol
- Details
- Category: Research
For many people with high cholesterol, statins serve as the first line of treatment. However, some patients are unable to effectively reduce their low-density lipoprotein cholesterol (LDL cholesterol) or "bad cholesterol" levels with statins, the most commonly used medication to treat high cholesterol, due to their bodies' inability to tolerate or sufficiently respond to the medicine.
Drug offers new pain management therapy for diabetics
- Details
- Category: Research
A study from the University of Calgary's Hotchkiss Brain Institute shows there is evidence to support a new drug therapy called nabilone to treat diabetic neuropathy, or nerve pain. Researchers enrolled 60 patients with diabetic neuropathy in a 12-week placebo controlled clinical study. At the end of the study, patients reported less pain and an improvement in sleep and anxiety when taking nabilone as compared to the placebo.
Insights into a new therapy for a rare form of cystic fibrosis
- Details
- Category: Research
Scientists at the Hospital for Sick Children in Toronto have established that a drug recently approved by the U.S. Food and Drug Administration to treat a rare form of cystic fibrosis works in an unconventional way. Their results reveal new possibilities for treating various forms of cystic fibrosis.
More Pharma News ...
- Researchers at the doorstep of stem cell therapies for MS, other myelin disorders
- Antidepressants linked to increased risk of stroke, but risk is low
- Antibiotic shows promise in treating extensively drug-resistant tuberculosis
- New malaria drug requires just one dose and appears twice as effective as existing regimen
- Cold viruses point the way to new cancer therapies
- Target for obesity drugs comes into focus
- Strategies proposed to improve impact of comparative effectiveness studies